Long noncoding RNAs (lncRNA) that are associated with immune checkpoints have not
been identified, and the mechanism by which such lncRNAs might regulate the expression …

Long non-coding RNAs (lncRNAs) could modulate expression of immune checkpoints
(ICPs) in tumor-immune. However, precise functions in immunity and potential for predicting …

Cancer immunotherapy is a major breakthrough in the history of tumor therapy in the last
decade. Immune checkpoint inhibitors blocking CTLA-4/B7 or PD-1/PD-L1 pathways have …

Long noncoding RNAs (lncRNAs) have multiple functions in the regulation of cellular
homeostasis. In recent years, numerous studies have shown that tumor-associated lncRNAs …

Long non-coding RNAs (lncRNAs) could modulate expression of immune checkpoints
(ICPs) by cooperating with immunity genes in tumor immunization. However, precise …

Non‐coding RNAs (ncRNAs) have attracted extensive attention due to their vital roles in
tumorigenesis and progression, especially in the immunotherapy resistance. Tumor …

At present, the incidence of cancer is becoming more and more common, but its treatment
has always been a problem. Although a small number of cancers can be treated, the …

Long noncoding RNAs (lncRNAs) show multiple functions, including immune response.
Recently, the immune‐related lncRNAs have been reported in some cancers. We first …

Long non-coding RNAs (lncRNAs) play pivotal roles in regulating immune responses,
immune cell differentiation, activation, and inflammatory processes. In cancer, they are …

T-cell-based immunotherapies, particularly immune checkpoint inhibitors, are promising
treatments for various cancers. However, a large subset of patients develop primary or …